Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

Healthcare Biotechnology
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > maybe next week they says something...like:
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by Alba1314on Jan 28, 2019 9:04am
50 Views
Post# 29288453

RE:RE:RE:RE:RE:maybe next week they says something...like:

RE:RE:RE:RE:RE:maybe next week they says something...like:There is no such law that requires a company to return the phone calls/emails of it's shareholders. There may be company bylaws and such, but barring that no legal requirement. Shareholders can always try to vote Rae out at the GM...if there is one. Your scenario about opening your won public company doesnt apply here. This company has been active in research and testing for a number of years. You knew the risks (or should have) before buying any stock. This is BIOTECH. What's happening with iCO is hardly unusual. It's just happening to you...and me...and the others invested. It sucks, to be sure. But there's nothing illegal going on here. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities